检索

期
标题
作者
编号 6 (2023)
Impact of systemic menopausal hormone therapy on symptoms of urinary incontinence in postmenopausal women
Makovskaya D., Apolikhina I., Gorbunova E., Yureneva S.
PDF
(Rus)
编号 9 (2023)
The use of non-hormonal medications for the correction of menopausal disorders: before, instead or together with menopausal hormone therapy
Tabeeva G., Smetnik A., Ermakova E.
PDF
(Rus)
编号 4 (2023)
Impact of hormone therapy on the overall and relapse-free survival of patients receiving treatment for ovarian cancer
Babaeva N., Yureneva S., Aleshikova O., Yakushevskaya O., Ashrafyan L.
PDF
(Rus)
编号 4 (2023)
Effectiveness of early start of menopausal hormone therapy in the menopausal transition: comparative analysis of therapy
Gasparyan S., Chotchaeva A., Karpov S.
PDF
(Rus)
编号 4 (2023)
Impact of menopausal hormone therapy on immune system parameters
Averyanova M., Yureneva S., Kiseleva V., Yakushevskaya O., Iskusnykh M., Elchaninov A., Fatkhudinov T., Vishnyakova P.
PDF
(Rus)
编号 11 (2023)
Russian eligibility criteria for menopausal hormone therapy in patients with cardiovascular and metabolic diseases
Shlyakhto E., Sukhikh G., Serov V., Dedov I., Arutyunov G., Suchkov I., Orlova Y., Andreeva E., Yureneva S., Yavelov I., Yarmolinskaya M., Villevalde S., Grigoryan O., Dudinskaya E., Ilyukhin E., Koziolova N., Sergienko I., Smetnik A., Tapilskaya N.
PDF
(Rus)
编号 8 (2023)
Menopause in rheumatology: what is important for gynecologist to know?
Panevin T., Smetnik A.
PDF
(Rus)
编号 12 (2020)
Estrogen therapy: from science to practical solutions
Bondarenko K., Dobrokhotova Y., Nasyrova N., Shadrova P.
PDF
(Rus)
编号 6 (2022)
Menopausal syndrome: possibilities of metabolic therapy
Ilyina I.
PDF
(Rus)
编号 1S (2020): Supplement
Correction of climacteric disorders in patients with breast cancer: current methods and prospects
Smetnik A., Rodionov V., Kometova V.
PDF
(Rus)
编号 7 (2018)
Menopause and menopausal status in a woman
Yureneva S., Ermakova E.
PDF
(Rus)
编号 11 (2017)
Menopausal hormone therapy and cervical cancer: A current view of the problem
Yakushevskaya O., Yureneva S., Khabas G., Protasova A.
PDF
(Rus)
编号 5 (2021)
Alternative and complementary therapy for menopausal disorders after radical treatment for breast cancer
Yakushevskaya O., Yureneva S., Protasova A., Shabalova O.
PDF
(Rus)
编号 2 (2020)
Management of menopausal women with a history of endometriosis
Ermakova E., Yureneva S.
PDF
(Rus)
编号 11 (2015)
CONSERVATIVE APPROACHES TO CORRECTING POSTMENOPAUSAL UROGENITAL DISORDERS
Lebedenko E., Mikhel’son A., Aleksanyan A., Rozenberg I., Novikova E., Minkina G., Selikhova M., Katkova N.
PDF
(Rus)
编号 6 (2018)
Evolution of the goals of menopausal hormone therapy. From treatment for hot flushes to the new horizons of cardiometabolic protection
Yureneva S., Dubrovina A.
PDF
(Rus)
编号 5 (2015)
UROGENITAL SYNDROME IN MENOPAUSE: THERAPY POSSIBILITIES
Balan V., Kovaleva L.
PDF
(Rus)
编号 10 (2022)
Rationale for the choice of menopausal hormone therapy if treatment switching is needed in the context of a personalized approach
Tapilskaya N., Bespalova O., Kogan I.
PDF
(Rus)
编号 9 (2021)
Menopausal hormone therapy for rheumatic diseases (gout)
Panevin T., Yureneva S.
PDF
(Rus)
编号 5 (2020)
THE ENDOMETRIUM AS A TARGET ORGAN IN POSTMENOPAUSAL WOMEN
ANDREEVA E., SHEREMETYEVA E., GRIGORYAN O., MIKHEEV R., ABSATAROVA Y.
PDF
(Rus)
编号 7 (2019)
Rational approach to hormonal therapy among women after 40 years
Dubrovina S.
PDF
(Rus)
编号 4 (2018)
Characteristics of risk factors for dementia in women: a possible preventive role of menopausal hormone therapy
Yureneva S., Ilyina L.
PDF
(Rus)
编号 4 (2021)
Gynecological aspects of the management of children with malignant blood diseases and similar conditions
Kokhreidze N., Alieva K., Ulrikh E., Ekushev K., Paina O., Zubarovskaya L., Efimova-Korzeneva O.
PDF
(Rus)
编号 7 (2020)
The hormonal profile and clinical manifestations of androgen deficiency in menopausal women and the current aspects associated with using hormone therapy
Shevtsova M., Tskhovrebova L., Gavisova A.
PDF
(Rus)
编号 1 (2016)
MENOPAUSAL HORMONE THERAPY: NEW POSSIBILITIES OF REHABILITATION IN ONCOLOGY
Payanidi Y., Zhordania K., Balan V.
PDF
(Rus)
编号 6 (2015)
OPTIMIZATION OF MENOPAUSAL HORMONE THERAPY-RELATED RISKS: THERAPY WITH TRANSDERMAL ESTROGENS ALONE OR IN COMBINATION WITH MICRONIZED PROGESTERONE. ADVANTAGES AGAINST METABOLIC RISKS AND ARTERIAL THROMBOSIS
Yureneva S.
PDF
(Rus)
编号 3 (2020)
Risk and benefits of menopausal hormonal therapy
Balan V., Andreeva E., Yureneva S., Tkacheva O., Ilyukhin E.
PDF
(Rus)
编号 5 (2019)
Menopause, obesity, and comorbidity: possibilities of menopausal hormone therapy
Protasova A., Yureneva S., Bairamova N., Komedina V.
PDF
(Rus)
编号 12 (2017)
The evidence base of the efficiency of treatment for menopausal syndrome with intravaginal hormonal agents
Chilova R., Chushkov Y., Proklova G.
PDF
(Rus)
编号 9 (2014)
Experience with micronized progesterone used in combined hormone therapy in periand postmenopausal women
Yarmolinskaya M.
PDF
(Rus)
编号 11 (2021)
Evaluation of patients’ satisfaction with Angeliq Micro in real clinical practice after 13 cycles of treatment in Russia
Yureneva S., Prokofieva S., Spiridonova N., Yurasova E., Ilyina L.
PDF
(Rus)
编号 6 (2021)
The problem of sarcopenia in postmenopausal women. Prevention opportunities
Sandakova E., Zhukovskaya I., Timofeeva E.
PDF
(Rus)
编号 1 (2019)
Menopausal vasomotor symptoms: social aspects, dynamics, cardiometabolic risks, hormone therapy options
Yureneva S., Ilyina L., Ebzieva Z.
PDF
(Rus)
编号 11 (2014)
Nonhormonal treatments for abnormal menopause
Serov V., Zimovina U., Blinov D., Sandakova E.
PDF
(Rus)
编号 8 (2022)
Impact of menopausal hormone therapy on the development and progression of cervical and endometrial cancers
Yakushevskaya O., Babaeva N., Yureneva S., Ashrafyan L.
PDF
(Rus)
编号 5 (2017)
The results of the second wave of investigation of the profile of patients with hormone-dependent conditions and magnesium deficiency
Makatsaria A., Dadak C., Bitsadze V., Solopova A., Khamani N.
PDF
(Rus)
编号 3 (2017)
Menopausal hormone therapy and risk of coronary heart disease
Yureneva S., Ilyina L.
PDF
(Rus)
编号 12 (2021)
The breast and sex hormones
Smetnik A., Rodionov V., Kometova V., Burmenskaya O., Dardyk M., Sencha A., Ermakova E., Ashrafyan L.
PDF
(Rus)
编号 3 (2020)
Current possibilities of using natural nonhormonal agents for climacteric syndrome
Mubarakshina O., Somova M., Batishcheva G., Mubarakshin E., Karpova E.
PDF
(Rus)
编号 9 (2019)
Mental aspects and fat metabolic disturbance in menopause
Andreeva E., Sheremetyeva E.
PDF
(Rus)
编号 1 (2018)
EVALUATION OF THE CARDIOVASCULAR SAFETY OF MENOPAUSAL HORMONE THERAPY IN EARLY POSTMENOPAUSAL WOMEN
SALOV I., TOLSTOV S., REBROV A.
PDF
(Rus)
编号 3 (2022)
Premature ovarian failure: an arsenal of approaches
Dubrovina S., Aleksandrina A.
PDF
(Rus)
编号 12 (2021)
Menopausal hormone therapy for rheumatic diseases: osteoarthritis
Panevin T., Yureneva S., Zotkin E.
PDF
(Rus)
1 - 43 的 43 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##